Oculis Holding AG
OCS | IC
Overview
Corporate Details
- ISIN(s):
- CH1242303498 (+1 more)
- LEI:
- 5067005370C2KK324336
- Country:
- Switzerland
- Address:
- Bahnhofstrasse 7, 6300 Zug
- Website:
- https://www.oculis.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Oculis Holding AG is a Swiss biopharma company developing innovative eye treatments. Its focus is on addressing major unmet medical needs in ophthalmology.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-01 10:00 |
Capital/Financing Update
Oculis hækkar lánsheimild sína og fær aðgang að allt að 100 milljónum CHF
|
Icelandic | 8.1 KB | |
| 2025-08-01 10:00 |
Capital/Financing Update
Oculis Upsized Loan Facility to Access up to CHF 100 million
|
English | 7.1 KB | |
| 2025-07-09 22:05 |
Directors' Dealings
Oculis Publishes Notifications of Transactions by Persons Discharging Manageria…
|
English | 948 bytes | |
| 2025-06-09 22:05 |
Directors' Dealings
Oculis Publishes Notifications of Transactions by Persons Discharging Manageria…
|
English | 940 bytes | |
| 2025-06-05 10:00 |
Declaration of Voting Results & Voting Rights Announcements
Oculis birtir niðurstöður aðalfundar 2025
|
Icelandic | 7.7 KB | |
| 2025-06-05 10:00 |
AGM Report
Oculis Publishes Results of 2025 Annual General Meeting
|
English | 6.4 KB | |
| 2025-06-03 23:00 |
Directors' Dealings
Oculis Publishes Notifications of Transactions by Persons Discharging Manageria…
|
English | 949 bytes | |
| 2025-06-03 10:00 |
Regulatory News Service
Oculis to Participate in Upcoming June Investor Conferences
|
English | 4.3 KB | |
| 2025-05-09 22:05 |
General Meeting Notice
Oculis birtir boð á aðalfund
|
Icelandic | 4.6 KB | |
| 2025-05-09 22:05 |
General Meeting Notice
Oculis Publishes Invitation to the Annual General Meeting
|
English | 4.2 KB | |
| 2025-05-09 21:05 |
General Meeting Notice
Oculis Publishes Invitation to the ..
|
Icelandic | 4.6 KB | |
| 2025-05-09 21:05 |
General Meeting Notice
Oculis Publishes Invitation to the ..
|
English | 4.2 KB | |
| 2025-05-08 22:05 |
Earnings Release
Oculis birtir uppgjör fyrir fyrsta ársfjórðung 2025 og kynnir áfanga í rekstri …
|
Icelandic | 22.3 KB | |
| 2025-05-08 22:05 |
Earnings Release
Oculis Reports Q1 Financial Results and Provides Company Update
|
English | 19.6 KB | |
| 2025-05-08 21:05 |
Earnings Release
Oculis Reports Q1 Financial Results..
|
Icelandic | 22.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |